Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Non GLP, non-guideline, animal experimental study. Restrictions in reporting but otherwise adequate for assessment.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1983
Report date:
1983

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
The acute oral toxicity of Cetiol R was tested in an approximate manner on 5 male and 5 female rats. A quantity of 2000 mg of the test substance/kg bodyweight in a 2 % aqueous carboxymethyl cellulose preparation (w/w) was administered to the test animals on one single occasion by gavage. After
treatment the animals were observed over a period of 14 days.
GLP compliance:
no
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Soybean oil, epoxidized, reaction products with methanol
EC Number:
287-837-7
EC Name:
Soybean oil, epoxidized, reaction products with methanol
Cas Number:
85586-35-2
Molecular formula:
C H4 O . Unspecified
IUPAC Name:
1-({13-[(1-{2,3-bis[(9,13-dihydroxy-10,12-dimethoxyoctadecanoyl)oxy]propoxy}-10-methoxy-1-oxooctadecan-9-yl)oxy]-9-hydroxy-10,12-dimethoxyoctadecanoyl}oxy)-3-[(9-hydroxy-10-methoxyoctadecanoyl)oxy]propan-2-yl 9,13-dihydroxy-10,12-dimethoxyoctadecanoate; 1-[(9,13-dihydroxy-10,12-dimethoxyoctadecanoyl)oxy]-3-[(9-hydroxy-10-methoxyoctadecanoyl)oxy]propan-2-yl 9,13-dihydroxy-10,12-dimethoxyoctadecanoate; 3-({8-[3-(3-hydroxy-2-methoxyoctyl)oxiran-2-yl]octanoyl}oxy)-2-[(8-{3-[(3-pentyloxiran-2-yl)methyl]oxiran-2-yl}octanoyl)oxy]propyl 9-hydroxy-10-methoxyoctadecanoate; 3-[(8-{3-[3-({1-[3-({8-[3-(3-hydroxy-2-methoxyoctyl)oxiran-2-yl]octanoyl}oxy)-2-[(8-{3-[(3-pentyloxiran-2-yl)methyl]oxiran-2-yl}octanoyl)oxy]propoxy]-10-methoxy-1-oxooctadecan-9-yl}oxy)-2-methoxyoctyl]oxiran-2-yl}octanoyl)oxy]-2-[(8-{3-[(3-pentyloxiran-2-yl)methyl]oxiran-2-yl}octanoyl)oxy]propyl 9-hydroxy-10-methoxyoctadecanoate
Details on test material:
- Name of test material (as cited in study report): Cetiol R
- Physical state: clear, yellow, viscous liquid.

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
- Average male body weight: 219 g
- Average female body weight: 165 g
- Animals were fasted for 16 hours prior to dosing

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
CMC (carboxymethyl cellulose)
Details on oral exposure:
Concentration in vehicle: 2%


VEHICLE
- Concentration in vehicle:
- Amount of vehicle (if gavage):
- Justification for choice of vehicle:
- Lot/batch no. (if required):
- Purity:

MAXIMUM DOSE VOLUME APPLIED:

DOSAGE PREPARATION (if unusual):

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose:
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of weighing: 48 hours, 7 and 14 days
- Necropsy of survivors performed: yes, by means of an overdose of aranaesthetic and dissected.
- Other examinations performed: clinical signs, body weight, pathology.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
none
Clinical signs:
other: No intoxication symptoms were observed.
Gross pathology:
No anatomicopathological changes in the inner organs or in the body cavities were found.

Applicant's summary and conclusion